| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
135,340,000 |
| Market
Cap: |
650.99(M) |
| Last
Volume: |
11,363,101 |
Avg
Vol: |
11,331,682 |
| 52
Week Range: |
$1.94 - $5.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
3,439,830 |
4,023,225 |
| Total Buy Value |
$0 |
$0 |
$10,277,564 |
$11,106,809 |
| Total People Bought |
0 |
0 |
12 |
12 |
| Total Buy Transactions |
0 |
0 |
14 |
42 |
| Total Shares Sold |
0 |
187,843 |
187,843 |
187,843 |
| Total Sell Value |
$0 |
$885,322 |
$885,322 |
$885,322 |
| Total People Sold |
0 |
3 |
3 |
3 |
| Total Sell Transactions |
0 |
3 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ramsay David A |
Director |
– • – |
2019-06-17 |
4 |
B |
$2.37 |
$59,550 |
D/D |
25,000 |
48,570 |
2.39 |
- |
|
| Hawkins Richard J |
Director |
– • – |
2019-05-15 |
4 |
S |
$11.16 |
$116,167 |
D/D |
(10,409) |
0 |
|
- |
|
| Hawkins Richard J |
Director |
– • – |
2019-05-14 |
4 |
S |
$11.07 |
$161,455 |
D/D |
(14,591) |
10,409 |
|
- |
|
| Hawkins Richard J |
Director |
– • – |
2019-05-14 |
4 |
OE |
$0.52 |
$13,013 |
D/D |
25,000 |
25,000 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-05-02 |
4 |
AS |
$10.82 |
$40,024 |
D/D |
(3,700) |
0 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-05-02 |
4 |
OE |
$1.51 |
$5,587 |
D/D |
3,700 |
3,700 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-05-01 |
4 |
AS |
$10.76 |
$40,903 |
D/D |
(3,800) |
0 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-05-01 |
4 |
OE |
$1.51 |
$5,738 |
D/D |
3,800 |
3,800 |
|
- |
|
| Jouhikainen Jaakko Taneli |
President and COO |
• – – |
2019-04-08 |
4 |
AS |
$9.04 |
$147,689 |
D/D |
(16,336) |
167,569 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-08 |
4 |
AS |
$9.04 |
$42,780 |
D/D |
(4,734) |
0 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-08 |
4 |
OE |
$1.51 |
$7,148 |
D/D |
4,734 |
4,734 |
|
- |
|
| Jouhikainen Jaakko Taneli |
President and COO |
• – – |
2019-04-05 |
4 |
AS |
$9.00 |
$7,641 |
D/D |
(849) |
183,905 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-05 |
4 |
AS |
$9.00 |
$2,881 |
D/D |
(320) |
0 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-05 |
4 |
OE |
$1.51 |
$483 |
D/D |
320 |
320 |
|
- |
|
| Jouhikainen Jaakko Taneli |
President and COO |
• – – |
2019-04-04 |
4 |
AS |
$9.00 |
$70,335 |
D/D |
(7,815) |
184,754 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-04 |
4 |
AS |
$9.00 |
$22,014 |
D/D |
(2,446) |
0 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2019-04-04 |
4 |
OE |
$1.51 |
$3,693 |
D/D |
2,446 |
2,446 |
|
- |
|
| Elam Nevan C |
Director |
– • – |
2019-02-04 |
4 |
OE |
$0.19 |
$4,120 |
D/D |
21,682 |
21,682 |
|
- |
|
| Neville Robert N |
Chief Executive Officer |
• • – |
2018-12-21 |
4 |
B |
$6.38 |
$149,994 |
D/D |
23,517 |
498,028 |
2.81 |
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2018-11-01 |
4 |
AS |
$9.22 |
$170,476 |
D/D |
(18,480) |
0 |
|
- |
|
| Jouhikainen Jaakko Taneli |
See Remarks |
• – – |
2018-06-12 |
4 |
AS |
$12.10 |
$163,300 |
D/D |
(13,494) |
192,569 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2018-06-12 |
4 |
AS |
$12.08 |
$47,105 |
D/D |
(3,900) |
18,480 |
|
- |
|
| Neville Robert N |
Chief Executive Officer |
• • – |
2018-06-12 |
4 |
AS |
$12.09 |
$162,586 |
D/D |
(13,445) |
474,511 |
|
- |
|
| Jouhikainen Jaakko Taneli |
See Remarks |
• – – |
2018-06-11 |
4 |
AS |
$12.02 |
$19,539 |
D/D |
(1,625) |
206,063 |
|
- |
|
| Lowrance David L |
Chief Financial Officer |
• – – |
2018-06-11 |
4 |
AS |
$12.05 |
$8,436 |
D/D |
(700) |
22,380 |
|
- |
|
179 Records found
|
|
Page 6 of 8 |
|
|
0.22 (4.79%) 
